View Older Stories View More Recent Stories

Feb 4, 2025 10:54AM Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put into quarter results
Feb 4, 2025 04:42AM Novo Nordisk (NVO) call put ratio 1.5 calls to 1 put into quarter results
Feb 2, 2025 08:21AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 31, 2025 08:32AM Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial's Design - Hagens Berman
Jan 30, 2025 05:49PM NVO INVESTOR NOTICE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 30, 2025 04:39PM ROSEN, A TOP RANKED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Jan 30, 2025 01:12PM Eli Lilly & Co. (LLY), Novo (NVO) see mid-day upside
Jan 29, 2025 04:00PM NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 28, 2025 08:45PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 28, 2025 04:59PM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) following latest Ozempic approval
Jan 28, 2025 02:28PM FDA approves Novo Nordisk's (NVO) Ozempic as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
Jan 28, 2025 09:08AM Novo Nordisk (NVO) sees pre-open selling pressure
Jan 26, 2025 10:24AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Jan 24, 2025 12:14PM BofA Securities Reiterates Buy Rating on Eli Lilly (LLY)
Jan 24, 2025 09:09AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO) Amid Solid SubQ Amycretin Results
Jan 24, 2025 07:13AM Novo Nordisk (NVO) successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Jan 24, 2025 06:33AM Novo Nordisk (NVO) call put ratio 1 call to 1 put into share price up before the bell
Jan 23, 2025 05:17AM Novo Nordisk (NVO) call put ratio 2.5 calls to 1 put
Jan 21, 2025 04:51AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 21, 2025 04:20AM Novo Nordisk (NVO) PT Lowered to $90 at CFRA
Jan 17, 2025 08:08AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 17, 2025 08:02AM Novo's (NVO) Ozempic, Wegovy Targeted In Medicare Price Negotiations - Bloomberg
Jan 17, 2025 07:16AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK798 at Guggenheim
Jan 17, 2025 07:13AM Novo Nordisk (NVO) : Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
Jan 15, 2025 04:51AM Novo Nordisk (NVO) call put ratio 1 call to 1 put as share price pulls back
Jan 8, 2025 06:31AM Novo Nordisk (NVO) and Valo Health expand collaboration to discover and develop novel treatments for cardiometabolic diseases
Jan 7, 2025 11:33PM UBS Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Buy
Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
Jan 7, 2025 05:07AM Bernstein SocGen Group Upgrades Novo Nordisk (NOVOB:DC) (NVO) to Market Perform
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Dec 23, 2024 08:22AM Novo Nordisk (NVO) PT Lowered to $105 at BMO Capital
Dec 23, 2024 05:38AM Novo Nordisk (NVO) options active on 195K contracts amid sharp move lower
Dec 23, 2024 05:30AM KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results
Dec 23, 2024 02:00AM Bernstein SocGen Group Reiterates Underperform Rating on Novo Nordisk (NOVOB:DC) (NVO)
Dec 20, 2024 03:44PM Novo Nordisk (NVO) January 3 weekly 110 and June 115 calls active as share price down 17.8% after releasing Cagrisema data
Dec 20, 2024 02:12PM Novo Nordisk (NVO) PT Lowered to $105 at BMO Capital
Dec 20, 2024 10:57AM Novo Nordisk (NVO) call put ratio 1.7 calls to 1 put after releasing Cagrisema data
Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations
Dec 20, 2024 06:19AM Novo Nordisk (NVO) reports data from CagriSema REDEFINE 1 trial
Dec 19, 2024 09:13AM Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended
Dec 18, 2024 08:57AM Novo Nordisk (NVO) Completes $16.5B Acquisition of Catalent
Dec 13, 2024 12:15PM CFRA Starts Novo Nordisk (NVO) at Hold
Dec 13, 2024 10:56AM Ozempic Study Found Small Number Of Patients With Vision Loss - Bloomberg
Dec 13, 2024 06:32AM Bernstein: 'GLP-1s vs. the Weight of the World'
Dec 13, 2024 12:00AM Buy this fast-growing European pharma stock, TD Cowen says
Dec 12, 2024 09:47AM TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO); Stock Named Best Idea 2025
Dec 9, 2024 07:00AM Bernstein: 'Could the lion's share of China GLP-1 market go to domestic players?'
Dec 6, 2024 04:00PM 3 catalysts that could send this GLP-1 stock surging: BofA
Dec 6, 2024 01:08PM Catalent (CTLT) and Novo Holdings (NVO) Receive European Commission Unconditional Approval for Pending Transaction
Dec 4, 2024 08:50AM BMO Capital: Five Key BioPharma Catalysts Through Year-End '24
View More Recent Stories View Older Stories